In addition to its glucose-dependent insulinotropic and glucagonostatic properties, GLP-1 also plays a physiological role in slowing GE [14] and the rate of GE in both healthy and T2D individuals appears to be determined in part by the GLP-1 response to intestinal nutrients. The gene discussed is GCG; the disease is type 2 diabetes mellitus.